BioCardia News

News

Ticker

BCDA

ISIN

US09060U6064

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

BioCardia Eulerpool News

BioCardia Stock News

BioCardia is being monitored by journalists and investors worldwide. We gather the latest BioCardia news here.

February 10·
Benzinga
BioCardia Completes Pre-Submission To FDA Under Q-Submission Program For Approval Of Helix Transendocardial Delivery Catheter For Intramyocardial Therapeutic And Diagnostic Agent Delivery
December 16·
Yahoo
BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA
November 13·
SeekingAlpha
BioCardia, Inc. (BCDA) Q3 2025 Earnings Call Transcript
November 6·
Yahoo
BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025
October 30·
Yahoo
BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
October 21·
Yahoo
BioCardia Inc. (BCDA): 2025 Product Pipeline and Strategy Analysis Report
September 20·
Yahoo
Bullish BioCardia Insider Buying Worth US$1.06m Yet To Pay Off
September 16·
Benzinga
Biocardia Inc Files For Offering Of Up To 2.8M Shares Of Common Stock Together With Up To 2.8M Common Warrants
August 11·
Benzinga
Earnings Scheduled For August 11, 2025
July 24·
Yahoo
BioCardia Submits Request for Clinical Data Review Meeting with Japan PMDA To Discuss Approval Pathway for CardiAMP® Cell Therapy in Ischemic Heart Failure
May 21·
Yahoo
BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025
May 15·
Yahoo
BioCardia Inc (BCDA) Q1 2025 Earnings Call Highlights: Progress in Cardiac Cell Therapy Amid ...
May 14·
Yahoo
BioCardia Reports First Quarter 2025 Business Highlights and Financial Results
May 14·
Benzinga
Earnings Scheduled For May 14, 2025
May 9·
Yahoo
BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025
May 6·
Yahoo
BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study
May 1·
Yahoo
Biotech Alert: Searches spiking for these stocks today
April 16·
Yahoo
DSMB recommends continuation of BioCardia’s cell therapy trial for heart failure
April 1·
Yahoo
BioCardia Inc (BCDA) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and Promising ...
March 28·
Yahoo
BioCardia Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

BioCardia Stock Press Releases

BioCardia regularly publishes news on the company's website that are relevant for investors.

August 10•
BioCardia
BioCardia Reports Second Quarter 2022 Business Highlights And Financial Results
August 4•
BioCardia
BioCardia to Host Q2 2022 Financial Results and Corporate Update Conference Call on August 10, 2022
August 1•
BioCardia
BioCardia Announces First Canadian Clinical Site for CardiAMP Cell Therapy Heart Failure Trial
July 12•
BioCardia
BioCardia to Participate in Upcoming Heart and Pulmonary Therapy Development Symposia
June 15•
BioCardia
BioCardia Announces US Patent on Imaging System for Targeting Cardiac Therapies
May 11•
BioCardia
BioCardia Reports First Quarter 2022 Business Highlights and Financial Results
May 4•
BioCardia
BioCardia to Host Q1 2022 Financial Results and Corporate Update Conference Call on May 11, 2022
April 12•
BioCardia
BioCardia Announces FDA Approval of Its IND for NK1R+ Mesenchymal Stem Cells for the Treatment of Patients Recovering from Acute Respiratory Distress due to COVID-19
March 29•
BioCardia
BioCardia Reports 2021 Financial Results and Recent Business Highlights
March 24•
BioCardia
BioCardia to Host 2021 Financial Results and Corporate Update Conference Call on March 29, 2022
March 22•
BioCardia
BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy Procedure
March 1•
BioCardia
BioCardia Receives No Objection Letter from Health Canada, Enabling Company to Expand CardiAMP Cell Therapy Heart Failure Trial into Canada
February 14•
BioCardia
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed
February 3•
BioCardia
BioCardia Receives FDA Breakthrough Device Designation for CardiAMP Cell Therapy System for Heart Failure
January 10•
BioCardia
BioCardia Announces Participation at the Upcoming Digital Medicine & Medtech Showcase and the H.C. Wainwright BioConnect Virtual Conference
December 15•
BioCardia
BioCardia Establishes New Manufacturing Facility to Enable Its Cell Therapy Product Candidates
November 10•
BioCardia
BioCardia Reports Third Quarter 2021 Financial Results and Business Highlights
November 8•
BioCardia
BioCardia To Release Third Quarter 2021 Financial Results November 10, 2021
October 21•
BioCardia
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
October 12•
BioCardia
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based Therapies
October 7•
BioCardia
BioCardia Announces First Cross-Over Patient Treated in CardiAMP Cell Therapy Heart Failure Trial
October 6•
BioCardia
BioCardia Announces Participation at the A.G.P. Biotech & Specialty Pharma Conference October 13, 2021 (Virtual Conference)
September 10•
BioCardia
CardiAMP Cell Therapy Heart Failure Trial to be Featured in Two Presentations at Heart Failure Society of America Annual Meeting 2021
September 9•
BioCardia
BioCardia Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 (Virtual Conference)
August 13•
BioCardia
BioCardia to Participate in Upcoming Investor Conferences
August 12•
BioCardia
BioCardia Reports Second Quarter 2021 Financial Results and Business Highlights
August 4•
BioCardia
BioCardia to Participate in a Fireside Chat at the BTIG Virtual Biotechnology Conference on August 10, 2021
July 15•
BioCardia
BioCardia Announces Japanese Patent on Imaging System for Targeting Cardiac Therapies
June 23•
BioCardia
BioCardia Announces Fourth Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed
June 22•
BioCardia
BioCardia to Present CardiAMP Cell Therapy Clinical Trial Data at European Society of Cardiology Heart Failure 2021

BioCardia News 2026

This page contains all current news, analysis and press releases for BioCardia stock (BCDA, ISIN: US09060U6064). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at BioCardia.